Novel human topoisomerase II inhibitors as anticancer agents
2018/29/N/NZ7/01726
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ7_15: Toksykologia
- NZ5_7: Leczenie chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu
Voivodeship: lubelskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 15 – announced on 2018-03-15
- Amount awarded
- 209 558 PLN
- Project start date
- 2019-04-12
- Project end date
- 2023-04-11
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Laptop. Cost: 5 000 PLN
- Lodówka. Cost: 3 700 PLN
Information in the final report
Publication in academic press/journals (2)
-
Thiosemicarbazide Derivatives Targeting Human TopoII α and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment
- Authors:
- Barbara Kaproń, Robert Czarnomysy, Dominika Radomska, Krzysztof Bielawski, Tomasz Plech
- Academic press:
- International journal of Molecular Sciences (year: 2023, volume: 24, pages: 5812), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms24065812 – link to the publication
-
Identification of the first-in-class dual inhibitors of human DNA topoisomerase IIα and indoleamine-2,3-dioxygenase 1 (IDO 1) with strong anticancer properties
- Authors:
- Barbara Kaproń, Anita Płazińska, Wojciech Płaziński, Tomasz Plech
- Academic press:
- Journal of Enzyme Inhibition and Medicinal Chemistry (year: 2023, volume: 38, pages: 192-202), Publisher: Taylor & Francis Group
- Status:
- Published
- DOI:
- 10.1080/14756366.2022.2140420 – link to the publication